Patheon contracted to make second drug by age-related diseases firm Biophytis
Patheon will make a candidate AMD treatment under a contract with French biotech Biophytis.
Archives for October 24, 2016
EAG Laboratories adds to environmental testing capabilities
EAG Laboratories has added 33,000-square-feet to its Easton, Maryland facility, with space for dedicated laboratories and equipment to support GLP-compliant ecotoxicology, environmental fate, metabolism, and other testing services.
Ashland opens Nanjing excipient plant citing growing local demand in light of new quality regulations
Ashland has opened a pharmaceutical excipients plant in Nanjing, China in a bid to capture growing local demand for modern formulation technologies.
IDT Biologika to provide live virus filling and finishing services to BARDA
IDT Biologika has been awarded a five-year contract to provide live virus filling and finishing services in a deal worth up to $50m.
Inovio's DNA vaccine trial on hold over delivery device shelf life concerns
The US FDA has placed a Phase III trial of Inovio’s candidate DNA cancer vaccine VGX-3100 on clinical hold over concerns about its delivery device.
Aduro told to halt cancer vaccine trial enrollment after listeria found in patient sample
The US FDA has told Aduro Biotech not to enrol subjects in trials of its listeria-based immunotherapies after one study subject tested positive for the bacteria.
CFDA: reports of clinical trial data fraud 'not fact based'
The Chinese Food and Drug Administration (CDFA) has fired back on lack of context in media reporting “80% of China’s clinical trial data are fraudulent.”
Everstone Capital buys stake in Rubicon Research citing delivery techs and ANDAs
Everstone Capital has acquired a 70% stake in drug delivery tech firm Rubicon Research Pvt for $33m (€30m).
Veeva expands clinical solution offerings, hires former PPD VP
Veeva has announced two new products and a series of new hires across its product management team after nearly doubling its customers over the past year.